Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition
Anne Fassl(Harvard University), Piotr Siciński(Harvard University), Deborah Butter(Dana-Farber Cancer Institute), Kornélia Polyák(Dana-Farber Cancer Institute), Nathanael S. Gray(Stanford University), Carmine De Angelis(Baylor College of Medicine), Rachel Schiff(Baylor College of Medicine), Bojana Jovanović(Harvard University), Myles Brown(Harvard University), Karolina Nowak(Dana-Farber Cancer Institute), Wojciech Michowski(Harvard University), Michael D. Cameron(Io Therapeutics (United States)), Walter Michael(Novartis (United States)), Alice Loo, Jean J. Zhao(Harvard University), Monther Abu-Remaileh(Neurosciences Institute), Baishan Jiang(Wuhan University), Piotr Stępień(Dana-Farber Cancer Institute), Qing Sheng(Zhejiang Sci-Tech University), Rinath Jeselsohn(Dana-Farber Cancer Institute), Maria Ericsson(Harvard University), Deborah Dillon(Harvard University), Christopher T. Brain(Novartis (United States)), Johann S. Bergholz(Broad Institute), Avery Feit(Brigham and Women's Hospital), Ralph Tiedt(Novartis (Switzerland)), Iga Stukan(Pomeranian Medical University), Tobias Otto(RWTH Aachen University), David M. Sabatini(Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry)
Cited by 105
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k